Shin Nippon Biomedical Laboratories, Ltd. (FRA:YB3)

FRA:YB3 Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 20, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	390	368	387	793	523	224
Market Cap Growth	-10.00%	-4.96%	-51.14%	51.44%	133.49%	20.59%
Enterprise Value	535	517	472	848	550	283
Last Close Price	9.20	8.80	8.67	16.99	10.96	4.64
PE Ratio	17.97	12.10	11.43	18.89	9.91	7.95
PS Ratio	2.29	1.84	2.39	4.56	3.98	1.93
PB Ratio	1.35	1.49	1.85	4.34	3.58	1.84
P/TBV Ratio	1.41	1.57	1.98	4.67	3.65	1.88
P/FCF Ratio	-	-	-	-	16.01	7.91
P/OCF Ratio	-	8.47	30.01	28.59	11.86	6.13
EV/Sales Ratio	3.11	2.58	2.91	4.88	4.18	2.44
EV/EBITDA Ratio	11.98	14.96	12.76	17.89	13.81	9.90
EV/EBIT Ratio	19.61	28.04	18.49	23.35	17.68	14.55
EV/FCF Ratio	-	-	-	-	16.82	10.00
Debt / Equity Ratio	0.78	0.86	0.77	0.71	0.46	0.80
Debt / EBITDA Ratio	7.85	6.16	4.34	2.74	1.70	3.41
Debt / FCF Ratio	-	-	-	-	2.07	3.45
Net Debt / Equity Ratio	0.49	0.56	0.46	0.31	0.11	0.34
Net Debt / EBITDA Ratio	4.94	4.01	2.58	1.20	0.40	1.45
Net Debt / FCF Ratio	-	-5.88	-2.40	-9.86	0.49	1.47
Asset Turnover	0.30	0.38	0.40	0.52	0.47	0.40
Inventory Turnover	1.17	1.24	1.24	2.06	1.91	1.87
Quick Ratio	0.58	0.63	0.69	0.73	0.79	0.86
Current Ratio	1.08	1.13	1.31	1.14	1.21	1.24
Return on Equity (ROE)	7.98%	13.10%	18.24%	26.26%	40.30%	22.82%
Return on Assets (ROA)	1.26%	2.21%	3.90%	6.79%	6.88%	4.16%
Return on Invested Capital (ROIC)	2.44%	4.30%	7.81%	14.49%	17.05%	9.42%
Return on Capital Employed (ROCE)	2.70%	4.70%	7.90%	14.50%	16.20%	10.10%
Earnings Yield	5.56%	8.27%	8.75%	5.29%	10.09%	12.58%
FCF Yield	-	-6.41%	-10.25%	-0.73%	6.25%	12.64%
Dividend Yield	3.25%	3.51%	3.53%	2.04%	2.03%	1.66%
Payout Ratio	-	42.65%	37.48%	41.01%	11.60%	5.65%
Buyback Yield / Dilution	-	-	-	0.00%	-	-
Total Shareholder Return	3.25%	3.51%	3.53%	2.04%	2.03%	1.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.